115 results
Page 2 of 6
424B5
8nced00dj3
12 Dec 22
Prospectus supplement for primary offering
7:12am
8-K
EX-99.1
2t9xp2h2lz0 37b4
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-10.4
a0vjt6kbh7sc21 a9ib
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-99.1
r2vfh1mmn
16 Nov 22
Regulation FD Disclosure
9:24am
8-K
EX-99.1
7n9crg2vqbsv0k150l
9 Nov 22
Societal CDMO Reports Third Quarter 2022 Financial Results
4:13pm
8-K
EX-99.1
st84y0tj2 ianoukt6e6
10 Aug 22
Societal CDMO Reports Second Quarter 2022 Financial Results
4:13pm
8-K
EX-99.1
iz0afmn9pg5hmwoz2taq
8 Jun 22
Corporate Presentation May 2022
7:35am
SC TO-I
EX-99
2m8h7ayj z9p
1 Jun 22
Issuer tender offer statement
5:05pm
8-K
EX-99.1
05ajd 7ij7
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.2
1r9x0mfjc0d
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
oppmiog2lpi
5 May 22
Societal Cdmo Signs Three-year Manufacturing and Supply Agreement with Infectopharm for Ritalin La® In Europe
7:05am
8-K
EX-99.1
jwhm8gy02nc6og70
21 Mar 22
Recro Announces Name Change to Societal Cdmo to Reflect Corporate Expansion and Transformation
8:00am
8-K
EX-99.1
p9r7yrmbssufj8276a
1 Mar 22
Recro Reports Fourth Quarter and Year End 2021 Financial Results
4:12pm
8-K
EX-99.2
nlkwmzrxh1gh2
1 Mar 22
Recro Reports Fourth Quarter and Year End 2021 Financial Results
4:12pm